Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2014-08-01

FDA Approved: EPIDUO — Supplemental Application (Galderma Laboratories, L.P.)

View source ↗

Summary

FDA approved a supplemental application for EPIDUO (adapalene and benzoyl peroxide) from Galderma Laboratories, L.P., likely affecting the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EPIDUO (adapalene and benzoyl peroxide)

Snippet

SUPPL AP for EPIDUO (ADAPALENE AND BENZOYL PEROXIDE)